Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck: less active for Abl and EGFR (L858R and L861Q). Phase 2/3.A diverse Src inhibitor.
Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck: less active for Abl and EGFR (L858R and L861Q). Phase 2/3.A diverse Src inhibitor.
Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck: less active for Abl and EGFR (L858R and L861Q). Phase 2/3.A diverse Src inhibitor.
Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck: less active for Abl and EGFR (L858R and L861Q). Phase 2/3.A diverse Src inhibitor.
Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck: less active for Abl and EGFR (L858R and L861Q). Phase 2/3.A diverse Src inhibitor.
Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck: less active for Abl and EGFR (L858R and L861Q). Phase 2/3.A diverse Src inhibitor.
Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck: less active for Abl and EGFR (L858R and L861Q). Phase 2/3.A diverse Src inhibitor.
Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck: less active for Abl and EGFR (L858R and L861Q). Phase 2/3.A diverse Src inhibitor.
Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck: less active for Abl and EGFR (L858R and L861Q). Phase 2/3.A diverse Src inhibitor.
Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck: less active for Abl and EGFR (L858R and L861Q). Phase 2/3.A diverse Src inhibitor.